Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Aisha Shaikh

General Nephrology · UPenn

View

Dr. Anna Gaddy

General Nephrology · MCW

View

Dr. Laura Maursetter

General Nephrology · UW

View

Dr. Lavinia Negrea

General Nephrology · CWRU

View

Dr. Chi-yuan Hsu

General Nephrology · UCSF

View

Dr. Adam Weinstein

General Nephrology · DaVita

View

Dr. Daniel Batlle

General Nephrology · Northwestern Medicine

View

Dr. Sushrut Waikar

General Nephrology · BMC

View

Dr. Keith Bellovich

General Nephrology · HFHS

View

Dr. Steven Fishbane

General Nephrology · Northwell Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideli...

    Jun 9, 2026DOI: 10.1161/cir.0000000000001453Journal ArticleAHA

    Written by: Writing Committee MembersChiadi E NdumeleFatima RodriguezDave L DixonSadiya S KhanDebabrata MukherjeeMandeep BajajSripal BangaloreBiykem BozkurtKhadijah BreathettShoa L ClarkeIan H de BoerDavid H EllisonLorraine S EvangelistaSean P HeffronDhruv S KaziAmbar KulshreshthaIldiko LingvayCecilia C Low WangClaudia A MercadoJohn Magaña MortonIan J NeelandNeha PagidipatiTiffany M Powell-WileyJanani RangaswamiGoutham RaoNosheen RezaAnum SaeedWendy St PeterJ Bradley StarksMadeline SterlingAmy W TalbotAndrew H TranKatherine R TuttleLisa B VanWagnerAmanda R VestSalim S Virani

    Find these authors on Roon

    DE
    Dr. David Ellison
    General Nephrology · OHSU

    Summary

    AIM: The "2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome" retires, replaces, and expands upon the "2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults." The primary intended audience for this guideline is clinicians who care for patients across the spectrum of cardiovascular-kidney-metabolic syndrome, an interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes), chronic kidney disease, and cardiovascular disease.METHODS: A comprehensive literature search was conducted from October 29, 2024, to April 14, 2025, to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human subjects that were published since 2015 in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.STRUCTURE: The focus of this clinical practice guideline is to create a living, working document that provides current knowledge in the field of cardiovascular-kidney-metabolic syndrome aimed at all practicing cardiologists, endocrinologists, nephrologists, and primary care and specialty clinicians who manage these patients.
    DEDr. David Ellison

    Dr. David Ellison

    Nephrology · General Nephrology
    Oregon Health & Science University
    davidellison